Japan stocks set to rise after Merck announces new Covid treatment; China markets closed

日本 ニュース ニュース

Japan stocks set to rise after Merck announces new Covid treatment; China markets closed
日本 最新ニュース,日本 見出し
  • 📰 CNBC
  • ⏱ Reading Time:
  • 27 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 72%

Merck and Ridgeback Biotherapeutics announced Friday they’ve developed a drug which reduces the risk of hospitalization or death by around 50% in Covid patients.

they've developed a drug which reduces the risk of hospitalization or death by around 50% in Covid patients. If authorized by regulatory bodies, the drug could be the first oral antiviral medicine for Covid.

The companies plan to seek emergency authorization for the antiviral Covid treatment after the medicine showed "compelling results" in clinical trials.Currencies The U.S. dollar index, which tracks the greenback against a basket of its peers, was at 93.956 after a recent decline from above 94.4. The Japanese yen traded at 110.96 per dollar, stronger than levels around 112 seen against the greenback last week. The Australian dollar changed hands at $0.7279 following a bounce late last week from around $0.72.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

CNBC /  🏆 12. in US

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Covid-19: Girl's Covid death, and Scotland's passport 'teething problems'Covid-19: Girl's Covid death, and Scotland's passport 'teething problems'Five things you need to know about the coronavirus pandemic this Sunday.
続きを読む »

Merck COVID-19 treatment pill could be available by end of year, Dr. Adalja predictsMerck COVID-19 treatment pill could be available by end of year, Dr. Adalja predictsJohns Hopkins School of Public Health Dr. Amesh Adalja expresses his optimism for Merck's new coronavirus treatment on 'Fox News Live.'
続きを読む »

Merck says its experimental pill cuts COVID-19 hospitalizations and deaths by halfMerck says its experimental pill cuts COVID-19 hospitalizations and deaths by halfDrugmaker Merck says its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus.
続きを読む »

Before Merck backed COVID antiviral, Trump admin turned it downBefore Merck backed COVID antiviral, Trump admin turned it downTrump administration officials fought over whether — and ultimately declined — to fund the same antiviral drug that Merck announced yesterday significantly reduces hospitalizations and deaths among coronavirus patients. Why it matters: The Trump administration's decision almost certainly delayed the development of the drug. Having an effective antiviral pill during the Delta wave could have substantially reduced its death toll.Stay on top of the latest market trends and economic insights with Ax
続きを読む »

Covid booster shot's side effects similar to 2nd vaccine dose, CDC study findsCovid booster shot's side effects similar to 2nd vaccine dose, CDC study findsDo booster shots have side effects? Are booster shot side effects worse? A CDC study found that booster shot side effects were similar to the ones seen after the second dose.
続きを読む »



Render Time: 2025-03-12 15:03:12